Anti-tuberculosis drug resistance in Portugal

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 3, 2000, Pages 223-231

  Antunes, Maria L ^a,d   Aleixo Dias, J ^a   Antunes, A F ^a   Pereira, M F ^b   Raymundo, E ^c   Rodrigues, M F ^b  

^a Direccao Geral da Saude   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c Administracao Regl Saude Lisboa V   (Portugal)

^d NONE   (Portugal)

Author keywords

Multidrug resistance; Portugal; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PORTUGAL; PRIORITY JOURNAL;

EID: 0034061514     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. World Health Organization Global Tuberculosis Programme. Global Tuberculosis Control. WHO Report 1997. WHO/TB/ 97.225. Geneva, Switzerland: WHO, 1997: 1-149.
2. Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistant tuberculosis. Geneva, Switzerland: WHO, 1997: 1-47.
3. Cohn D L, Bustreo F, Raviglione M. Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clin Infect Dis 1997; 24 (Suppl 1): S121-S130.
4. Schwoebel V, Papillon F, Haeghbart S, et al. Surveillance de la tuberculose à bacilles multi-résistants en 1992. Bull Epidémiol Hebdomadaire 1993; 50: 235-236.
5. Warburton A R E, Jenkins P A, Waight P A, Watson J M. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales. Commun Dis Rep 1993; 3: R175-R179.
6. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-749.
7. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons -Florida and New York 1988-1991. MMWR Morb Mortal Wkly Rep 1991; 40: 585-591.
8. Edlin B R, Tokars J I, Grieco M H, et al. An outbreak of multidrug-resistant tuberculosis among hospitalised patients with the acquired immunodeficiency syndrome. N Eng J Med 1992; 326: 1514-1521.
9. Fischl M A, Uttamchandani R B, Daikos G L, et al. An outbreak of tuberculosis caused by multidrug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-183.
10. Dooley S W, Jarvis W R, Martone W J, Snider D E Jr. Multidrug-resistant tuberculosis [Editorial]. Ann Intern Med 1992; 117: 257-259.
11. Raviglione M, Sudre P, Rieder H L, et al. Secular trends of tuberculosis in Western Europe. Bull World Health Organ 1993; 71: 297-306.
12. Kochi A, Vareldzis B, Styblo K. Multidrug resistant tuberculosis and its control. Res Microbiol 1993; 144: 104-110.
13. New York City Department of Health. Tuberculosis in New York City, 1996: information summary. New York: New York City Department of Health, 1997.
14. Fujiwara P I, Fine Sherman L. Multidrug-resistant tuberculosis: many paths, same truth [Editorial]. Int J Tuberc Lung Dis 1997; 1: 297-298.
15. World Health Organization Global Tuberculosis Programme and International Union Against Tuberculosis and Lung Disease. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/94. 178. Geneva, Switzerland: WHO, 1994: 1-24.
16. Direcção-Geral da Saúde. Tuberculose em Portugal, 1995. Direcção-Geral da Saúde. Lisboa, 1996: 1-65.
17. Antunes M L. Tuberculose em Portugal. Acta Med Port 1995; 8 (II série): 559-565.
18. Kish L J. Survey sampling. New York, NY: John Wiley & Sons, 1965.
19. Khaled S, Boulahbal F. Enquête prospective sur la résistance primaire du bacille de la tuberculose aux antibiotiques. Méthodologie et résultats. Arch Inst Pasteur Algérie 1988; 56: 49-65.
20. Enarson D A, Rieder H L, Arnadottir T, Trébucq A. Tuberculosis guide for low income countries. 4th edition. Paris: International Union Against Tuberculosis and Lung Disease, 1996.
21. Collins C H, Grange J M, Yates M D. Organisation and practice in tuberculosis bacteriology. London: Butterworths, 1985.
22. Laszlo A, Rahman M, Raviglione M, Bustreo F, WHO/ IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1: 231-238.
23. World Health Organization, Tuberculosis programme and International Union Against Tuberculosis and Lung Disease. Guidelines for surveillance of drug resistance in tuberculosis. Int J Tuberc Lung Dis 1998; 2: 72-89.
24. World Health Organization. Global Tuberculosis Programme. Anti-tuberculosis drug resistance in the world. WHO/TB/ 97.229. Geneva, Switzerland: WHO, 1997.
25. Viskum K, Kok-Jensen A. Multidrug-resistant tuberculosis in Denmark 1993-1995. Int. J. Tuberc Lung Dis 1997; 1: 299-301.
26. Kent J. The epidemiology of multidrug-resistant TB in the US. Med Clin North Am 1993; 77: 1391-1408.
27. Mitchison D A. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 10-15.
28. Nunn P, Felten M. Surveillance of resistance to anti-tuberculous drugs in developing countries. Tubercle Lung Dis 1994; 75: 163-176.
29. Glynn J R, Jenkins P A, Fine P E M, et al. Pattern of initial and acquired antituberculosis drug resistance in Karonga district, Malawi. Lancet 1995; 345: 907-910.
30. Frieden T R, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
31. Jacobs R F. Multiple drug resistant tuberculosis. Clin Infect Dis 1994; 19: 1-10.
32. Frieden T R, Sherman L F, Maw K L, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. JAMA 1996; 276: 1229-1235.
33. Direcção-Geral da Saúde. SARA-Sistema de Alerta e Resposta Apropriada. Lisboa: Direcção-Geral da Saúde, 1997. (http:// www.dgsaude.min-saude.pt).
34. Mendes B, Gomes C, Henriques J, et al. Estudo da prevalência da resistência aos antibacilares. Rev Port Pneumol 1996; 11: 375-380.
35. Peres H, Bicó J. Tuberculose multirresistente - um problema ignorado em Portugal. Rev Port Pneumol 1996; 11: 381-385.
36. Kim S J, Bai G H, Hong Y P. Drug-resistant tuberculosis in Korea. Int J Tuberc Lung Dis 1997; 1: 302-308.
37. Direcção-Geral da Saúde. Tuberculose em Portugal, 1997. (Relatório preliminar) Lisboa: Direcção-Geral da Saúde, 1998: 1-12.
38. Ministério da Saúde. Saúde em Portugal: uma estratégia para o virar do Século, 1998-2002. Lisboa: Ministério da Saúde, 1998: 1-75.
39. Jansà J M, Serrano J, Caylà J A, et al. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis. Int J Tuberc Lung Dis 1998; 2: 140-146.
40. Angarano G, Carbonara S, Costa D, et al. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. Int J Tuberc Lung Dis 1998; 2: 303-311.